Regresar

Oligopeptidase B from Trypanosoma evansi: A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts

Abstract:

Serine oligopeptidases of trypanosomatids are emerging as important virulence factors and therapeutic targets in trypanosome infections. We report here the isolation and characterization of oligopeptidase B (OpdB) and its corresponding gene from Trypanosoma evansi, a pathogen of significant veterinary importance. The T. evansi opdB gene was present as a single copy per haploid genome containing an open reading frame of 2148 bp encoding a protein of 80.664 kDa. Purified OpdB hydrolyzed substrates with basic residues in P1 (kcat/Km for carbobenzyloxy-L-arginyl-L-arginyl-7-amido-4- methylcoumarin, 337 s-1·M-1) and exhibited potent arginyl carboxypeptidase activity (kcat/Km for Val-Lys-Arg ↓ Arg·OH, 231 s-1·mM-1). While not secreted, T. evansi released OpdB into the plasma of infected hosts where it retained catalytic activity. Plasma OpdB levels correlated with blood parasitemia. In vitro, OpdB cleaved the peptide hormone atrial natriuretic factor (ANF) at four sites: Arg3 ↓ Arg4, Arg 4 ↓ Ser5, Arg11 ↓ Ile12, and Arg27 ↓ Tyr28, thereby abrogating smooth muscle relaxant and prohypotensive properties of ANF. Circulating plasma ANF levels in T. evansi-infected rats were depressed from 130 to 8 pg·ml-1, and plasma ANF levels inversely correlated with plasma OpdB activity. The in vitro half-life of ANF in rat plasma was reduced 300-fold in plasma from T. evansi-infected rodents, which contains high levels of OpdB activity. Addition of OpdB inhibitors to cell-free plasma from infected rodents significantly abrogated this ANF hydrolysis. Furthermore the in vivo ANF half-life was reduced 5-fold in T. evansi-infected rats. Thus, we propose a role for OpdB in peptide hormone dysregulation in trypanosomiasis, specifically in generating the depressed plasma levels of ANF in mammals infected with T. evansi. © 2005 by The American Society for Biochemistry and Molecular Biology, Inc.